Genetic variations of the A13/A14 repeat located within the EGFR 3[prime] untranslated region have no oncogenic effect in patients with colorectal cancer.

Nasrin Sarafan-Vasseur 1 David Sefrioui 1, 2 David Tougeron 3 Aude Lamy 1, 4 France Blanchard 4 Florence Le Pessot 5 Frédéric Di Fiore 1, 2 Pierre Michel 1, 2 Stéphane Bézieau 6 Jean-Baptiste Latouche 1 Thierry Frebourg 1 Richard Sesboüé 1, *
* Auteur correspondant
1 GMFC - Génétique du cancer et des maladies neuropsychiatriques
2 Unité d'Oncologie Digestive
3 LITEC - Laboratoire Inflammation, Tissus épithéliaux et Cytokines
4 Service de génétique [Rouen]
5 Service d'Hépato-Gastroentérologie [Rouen]
6 Service de Génétique
Abstract : BACKGROUND: The EGFR 3[prime] untranslated region (UTR) harbors a polyadenine repeat which is polymorphic (A13/A14) and undergoes somatic deletions in microsatellite instability (MSI) colorectal cancer (CRC). These mutations could be oncogenic in colorectal tissue since they were shown to result into increased EGFR mRNA stability in CRC cell lines. METHODS: First, we determined in a case control study including 429 CRC patients corresponding to different groups selected or not on age of tumor onset and/or familial history and/or MSI, whether or not, the germline EGFR A13/A14 polymorphism constitutes a genetic risk factor for CRC; second, we investigated the frequency of somatic mutations of this repeat in 179 CRC and their impact on EGFR expression. RESULTS: No statistically significant difference in allelic frequencies of the EGFR polyA repeat polymorphism was observed between CRC patients and controls. Somatic mutations affecting the EGFR 3[prime]UTR polyA tract were detected in 47/80 (58.8%) MSI CRC versus 0/99 microsatellite stable (MSS) tumors. Comparative analysis in 21 CRC samples of EGFR expression, between tumor and non malignant tissues, using two independent methods showed that somatic mutations of the EGFR polyA repeat did not result into an EGFR mRNA increase. CONCLUSION: Germline and somatic genetic variations occurring within the EGFR 3[prime]UTR polyA tract have no impact on CRC genetic risk and EGFR expression, respectively. Genotyping of the EGFR polyA tract has no clinical utility to identify patients with a high risk for CRC or patients who could benefit from anti-EGFR antibodies.
Keywords : Colorectal cancer EGFR Polymorphism Microsatellite instability Targeted therapy
Type de document :
Article dans une revue
BMC Cancer, BioMed Central, 2013, 13 (1), pp.183. 〈10.1186/1471-2407-13-183〉
Liste complète des métadonnées

Littérature citée [30 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00813520
Contributeur : Ed. Bmc <>
Soumis le : lundi 15 avril 2013 - 17:05:48
Dernière modification le : mercredi 5 septembre 2018 - 13:30:09
Document(s) archivé(s) le : lundi 3 avril 2017 - 05:28:57

Fichiers

1471-2407-13-183.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Collections

COMUE-NORMANDIE | UNIV-POITIERS | LITEC | UNIROUEN

Citation

Nasrin Sarafan-Vasseur, David Sefrioui, David Tougeron, Aude Lamy, France Blanchard, et al.. Genetic variations of the A13/A14 repeat located within the EGFR 3[prime] untranslated region have no oncogenic effect in patients with colorectal cancer.. BMC Cancer, BioMed Central, 2013, 13 (1), pp.183. 〈10.1186/1471-2407-13-183〉. 〈inserm-00813520〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

406

Téléchargements de fichiers

260

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD